R. Binder

Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo.

W. Wernsdorfer, A. Adegnika, S. Issifou, 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.

B. Lell, P. Kremsner, S. Borrmann, 2001, The Journal of infectious diseases.

Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines.

B. Lell, P. Kremsner, J. Faucher, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

Xiaomin Wang, M. Holtgrewe, D. Beule, 2021, EClinicalMedicine.

Short-Course Artesunate Treatment of Uncomplicated Plasmodium falciparum Malaria in Gabon

B. Lell, A. Adegnika, S. Issifou, 2003, Antimicrobial Agents and Chemotherapy.

Fosmidomycin for malaria

Jochen Wiesner, J. Wiesner, H. Jomaa, 2002, The Lancet.

Polymorphisms in the parasite genes for pfcrt and pfmdr-1 as molecular markers for chloroquine resistance in Plasmodium falciparum in Lambaréné, Gabon

A. Adegnika, P. Kremsner, S. Borrmann, 2002, Parasitology Research.

Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children.

B. Lell, P. Kremsner, S. Borrmann, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evidence for the efficacy of artesunate in asymptomatic Plasmodium malariae infections.

B. Lell, P. Kremsner, S. Borrmann, 2002, The Journal of antimicrobial chemotherapy.

CONCISE Artesunate and Praziquantel for the Treatment of Schistosoma haematobium Infections: A Double-Blind, Randomized, Placebo-Controlled Study

B. Lell, P. Kremsner, S. Borrmann, 2001 .